PTC Therapeutics | PTCT - 流动负债



金融业
股票价格
USD
资产
USD 3.25B
现金及等价物
USD 1.05B
销售成本
USD 39.61M
流动资产
USD 2.62B
流动负债
USD 771.07M
债务
USD 286.94M
EBIT
USD 45.89M
EBITDA
USD 61.98M
员工
939
EPS每股收益
USD 0.92
股本和储备
USD -165.36M
销售毛利
USD 232.94M
债务利息支出
USD 3.25B
贷款资金
USD 535.52M
市值
USD 5.65B
净收入
USD -2.81M
营业费用
USD 226.67M
营业利润
USD 45.89M
普通股股本
USD 82.88M
PE价格收益
8.76
税前利润
USD -2.46M
销售收入
USD 361M
销售和管理费用
USD 73.89M
股票
USD 91.35M
贸易债权人
USD 40.45M
应收帐款人
USD 219.92M


流动负债 更改 日
Acadia Pharmaceuticals USD 361.44M 55.91M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amgen USD 25.5B 547M 2026-06
BioCryst Pharmaceuticals USD 208.85M 13.46M 2026-06
Biogen USD 3.92B 918.2M 2026-06
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Cytokinetics USD 181.43M 17.76M 2026-06
Daiichi Sankyo JPY 765.7B 119.32B 2026-06
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Gilead Sciences USD 11.02B 1.54B 2026-06
Incyte USD 1.31B 177.55M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Ironwood Pharmaceuticals USD 236.31M 5.91M 2026-03
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Novartis USD 31.75B 374M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Puma Biotechnology USD 82.73M 3.63M 2025-09
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
TG Therapeutics USD 268.49M 81.38M 2026-06
Ultragenyx Pharmaceutical USD 351M 26M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06
Xencor USD 81.86M 8.41M 2026-06